Computational pipeline for personalised cancer vaccine design
16 October 2024 | By
Ludwig Cancer Research researchers have designed and validated a computational pipeline which integrates molecular and genetic analyses.
List view / Grid view
16 October 2024 | By
Ludwig Cancer Research researchers have designed and validated a computational pipeline which integrates molecular and genetic analyses.
Cancer Research UK-funded researchers aim to identify targets for an ovarian cancer vaccine, which could prevent the disease at an early stage.
The mRNA vaccine candidate more effectively limited symptoms and disease duration in non-human primates.
The novel strategy demonstrates a strong immune response, both body-wide and specifically in the upper respiratory tract, in porcine models.
In this episode, we explore how mRNA technology could revolutionise cancer therapeutics.
Researchers screened over 2,000 small molecules and have now more than doubled the known compounds reported to induce trained immunity.
In this exclusive interview with Elicio Therapeutics, we explore the transformative potential of liquid biopsy in oncology drug development, particularly spotlighting its application in Elicio’s AMPLIFY-201 study of ELI-002, a promising therapeutic cancer vaccine candidate.
In an animal model, scientists have demonstrated that targeting Interleukin-10 during vaccine delivery enhances the vaccine’s ability to protect against infection.
PVP-037, identified through a small molecule screen, induces a more durable and broader immune response to vaccines.
A new assay has been developed which enables the detailing of intact proviral genomes of under-studied HIV strains.
The mouse model provides a new understanding of the fundamental aspects of KSHV, which will enable drug and vaccine development.
In animal studies, the new vaccine construct outperformed another PNAG-vaccine delivery system currently in human trials.
The vaccine provided complete protection with no detectable virus in the lungs and could be a routine part of people’s medical treatment.
This report provides insights into current research and future prospects from potential breakthroughs to global collaboration in pandemic preparedness.
The proof-of-concept study could lead to a cure for HIV that inactivates diverse strains across multiple cellular contexts.